These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16900573)

  • 1. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some fundamental issues with non-inferiority testing in active controlled trials.
    James Hung HM; Wang SJ; Tsong Y; Lawrence J; O'Neil RT
    Stat Med; 2003 Jan; 22(2):213-25. PubMed ID: 12520558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ; Hung HM
    Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new test of non-inferiority for anti-infective trials.
    Phillips KF
    Stat Med; 2003 Jan; 22(2):201-12. PubMed ID: 12520557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
    Carroll KJ
    Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority trials: the 'at least as good as' criterion with dichotomous data.
    Laster LL; Johnson MF; Kotler ML
    Stat Med; 2006 Apr; 25(7):1115-30. PubMed ID: 16381070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M; Chen X
    Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.